Literature DB >> 25883420

Cytotoxicity and Apoptosis Inducing Activities of 2-Amino-4H-chromene-3-carbonitrile Derivatives Loaded on Gold Nanoparticles Against Human Breast Cancer Cell Line T47D.

Zahra Saffari1, Maryam Farahnak Zarabi2, Hasan Aryapour3, Alireza Foroumadi4, Ali Farhangi5, Soheil Ghassemi5, Azim Akbarzadeh5.   

Abstract

Chemotherapy drugs, used for prevention of uncontrolled cell proliferation in certain tissues as well as inducing apoptosis in tumor cells, are important candidates for treatment of cancer. The synthesized 2-amino-4H-chromene-3-carbonitrile derivatives effective on cancerous cells resistant to other drugs such as Paclitaxel were used due to their ability in induction of apoptosis. The growth inhibitory and inducing apoptosis activities were determined. In order to make it target-oriented, the best compound was conjugated with gold nanoparticles (NPs) by aspartic acid with chemical reduction method. Cytotoxicity effect of 2-amino-4H-chromene-3-carbonitrile derivatives against the T47D breast cancer cell line was determined by MTT assay. The synthesis of gold NPs was confirmed by transmission electron microscopy, UV-Vis and dynamic light scattering. To assess the effects of compounds on the process of apoptosis, staining methods with acridine orange-ethidium bromide and Hoechst staining by fluorescence microscopy and DNA fragmentation by the diphenylamine method were used. The synthesized compounds containing two NH2 groups on benzene rings, demonstrated more cytotoxicity effect. The effect of conjugation with gold NPs and the induction of apoptosis were studied with the best compound. The cytotoxicity effects of the synthesized 2-amino-4H-chromene-3-carbonitrile compounds were changed by replacement of NO2 group on thiol ring with different chemical groups on the benzene ring. Analyses of treated cell lines by conjugated and non-conjugated forms of compounds verified their ability in inducing apoptosis while conjugated form demonstrated higher apoptosis.

Entities:  

Keywords:  2-Amino-4H-chromene-3-carbonitrile derivatives; Apoptosis; Beast cancer; Conjugating; Gold nanoparticles; T47D

Year:  2014        PMID: 25883420      PMCID: PMC4393388          DOI: 10.1007/s12291-014-0417-5

Source DB:  PubMed          Journal:  Indian J Clin Biochem        ISSN: 0970-1915


  34 in total

Review 1.  Assessing the risk of breast cancer.

Authors:  K Armstrong; A Eisen; B Weber
Journal:  N Engl J Med       Date:  2000-02-24       Impact factor: 91.245

Review 2.  Nanotechnology and medicine.

Authors:  James H Thrall
Journal:  Radiology       Date:  2004-02       Impact factor: 11.105

3.  Prevention of apoptosis by Bcl-2: release of cytochrome c from mitochondria blocked.

Authors:  J Yang; X Liu; K Bhalla; C N Kim; A M Ibrado; J Cai; T I Peng; D P Jones; X Wang
Journal:  Science       Date:  1997-02-21       Impact factor: 47.728

Review 4.  Cell death: the significance of apoptosis.

Authors:  A H Wyllie; J F Kerr; A R Currie
Journal:  Int Rev Cytol       Date:  1980

Review 5.  Dysregulation of apoptosis in cancer.

Authors:  J C Reed
Journal:  J Clin Oncol       Date:  1999-09       Impact factor: 44.544

6.  Synthesis and anticancer activity of lavendustin A derivatives containing arylethenylchromone substituents.

Authors:  Ki Yong Lee; Dong Hyuk Nam; Chang Sang Moon; Seon Hee Seo; Jae Yeol Lee; Yong Sup Lee
Journal:  Eur J Med Chem       Date:  2006-06-09       Impact factor: 6.514

7.  The in vitro inhibition of multidrug resistance by combined nanoparticulate titanium dioxide and UV irradition.

Authors:  Min Song; Renyun Zhang; Yongyuan Dai; Feng Gao; Huimei Chi; Gang Lv; Baoan Chen; Xuemei Wang
Journal:  Biomaterials       Date:  2006-04-04       Impact factor: 12.479

Review 8.  Apoptosis. Its significance in cancer and cancer therapy.

Authors:  J F Kerr; C M Winterford; B V Harmon
Journal:  Cancer       Date:  1994-04-15       Impact factor: 6.860

9.  Antivascular and antitumor evaluation of 2-amino-4-(3-bromo-4,5-dimethoxy-phenyl)-3-cyano-4H-chromenes, a novel series of anticancer agents.

Authors:  Henriette Gourdeau; Lorraine Leblond; Bettina Hamelin; Clemence Desputeau; Kelly Dong; Irenej Kianicka; Dominique Custeau; Chantal Boudreau; Lilianne Geerts; Sui-Xiong Cai; John Drewe; Denis Labrecque; Shailaja Kasibhatla; Ben Tseng
Journal:  Mol Cancer Ther       Date:  2004-11       Impact factor: 6.261

10.  Synthesis and antitumor efficacy of daunorubicin-loaded magnetic nanoparticles.

Authors:  Jun Wang; Baoan Chen; Jian Chen; Xiaohui Cai; Guohua Xia; Ran Liu; Pingsheng Chen; Yu Zhang; Xuemei Wang
Journal:  Int J Nanomedicine       Date:  2011-01-24
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.